CoChat

Epigenome-wide change and variation in DNA methylation in childhood: trajectories from birth to late adolescence

Open access

Published version of a preprint

The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.

Abstract

DNA methylation (DNAm) is known to play a pivotal role in childhood health and development, but a comprehensive characterization of genome-wide DNAm trajectories across this age period is currently lacking. We have therefore performed a series of epigenome-wide association studies in 5019 blood samples collected at multiple time-points from birth to late adolescence from 2348 participants of two large independent cohorts. DNAm profiles of autosomal CpG sites (CpGs) were generated using the Illumina Infinium HumanMethylation450 BeadChip. Change over time was widespread, observed at over one-half (53%) of CpGs. In most cases, DNAm was decreasing (36% of CpGs). Inter-individual variation in linear trajectories was similarly widespread (27% of CpGs). Evidence for non-linear change and inter-individual variation in non-linear trajectories was somewhat less common (11 and 8% of CpGs, respectively). Very little inter-individual variation in change was explained by sex differences (0.4% of CpGs) even though sex-specific DNAm was observed at 5% of CpGs. DNAm trajectories were distributed non-randomly across the genome. For example, CpGs with decreasing DNAm were enriched in gene bodies and enhancers and were annotated to genes enriched in immune-developmental functions. In contrast, CpGs with increasing DNAm were enriched in promoter regions and annotated to genes enriched in neurodevelopmental functions. These findings depict a methylome undergoing widespread and often non-linear change throughout childhood. They support a developmental role for DNA methylation that extends beyond birth into late adolescence and has implications for understanding life-long health and disease. DNAm trajectories can be visualized at http://epidelta.mrcieu.ac.uk.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/hmg/ddaa280

Cites

118 of 118 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Longitudinal sample sizes for (a) Generation R (N total children = 1399, N total DNAm samples = 2333) and (b) ALSPAC (N total children = 949, N total DNAm samples = 2686). Bolded numbers represent total sample size at each time-point; non-bolded number refers to overlapping samples between time-points.
Figure 1 Longitudinal sample sizes for (a) Generation R (N total children = 1399, N total DNAm samples = 2333) and (b) ALSPAC (N total children = 949, N total DNAm samples = 2686). Bolded numbers represent total sample size at each time-point; non-bolded number refers to overlapping samples between time-points.CC BY · PubMed Central
Figure 2 Scatterplots of within-cohort stability of DNA methylation showing (a) Spearman correlations, (b) intra-class correlation coefficients and (c) change estimates from birth to 6/7 years per CpG for Generation R and ALSPAC.
Figure 2 Scatterplots of within-cohort stability of DNA methylation showing (a) Spearman correlations, (b) intra-class correlation coefficients and (c) change estimates from birth to 6/7 years per CpG for Generation R and ALSPAC.CC BY · PubMed Central
Figure 3 DNAm levels of selected CpG sites across childhood. Parts (a–c) show CpG sites with linear change over time (Model 1). A typical site is shown in (a), the site with the largest observed change in (b) and with inter-individual variation in DNAm change (c). Parts (d–f) show CpG sites with non-linear change (Model 2). A Positive-Neutral trajectory is shown in (d), a Negative-Neutral trajectory in (e) and a Positive-More Positive-Less Positive in (f). Parts (g–i) show CpG sites with inter-individual variation in change (Model 2). A site with slope variation from birth is shown in (g), slope change variation at 6 in (h) and slope change variation at 9 in (i). Parts (j–l) show CpG sites with sex-specific DNAm. A site with stable sex differences is shown in (Model 3) (j), sex-specific slope in (Model 3) (k) and sex-specific slope change at 6 in (Model 2) (l).
Figure 3 DNAm levels of selected CpG sites across childhood. Parts (a–c) show CpG sites with linear change over time (Model 1). A typical site is shown in (a), the site with the largest observed change in (b) and with inter-individual variation in DNAm change (c). Parts (d–f) show CpG sites with non-linear change (Model 2). A Positive-Neutral trajectory is shown in (d), a Negative-Neutral trajectory in (e) and a Positive-More Positive-Less Positive in (f). Parts (g–i) show CpG sites with inter-individual variation in change (Model 2). A site with slope variation from birth is shown in (g), slope change variation at 6 in (h) and slope change variation at 9 in (i). Parts (j–l) show CpG sites with sex-specific DNAm. A site with stable sex differences is shown in (Model 3) (j), sex-specific slope in (Model 3) (k) and sex-specific slope change at 6 in (Model 2) (l).CC BY · PubMed Central
Figure 4 Overview of results from the three models. Model 1 (M1) was applied for overall change in DNA methylation and inter-individual variation in linear change; Model 2 (M2) for non-linear change in DNA methylation and inter-individual variation in non-linear change; and Model 3 (M3) for stable sex differences in DNA methylation and sex differences in change of DNA methylation (sex by time interaction). Percentages represent percentage of autosomal CpGs below Bonferroni-corrected threshold (P < 1 × 10−7).
Figure 4 Overview of results from the three models. Model 1 (M1) was applied for overall change in DNA methylation and inter-individual variation in linear change; Model 2 (M2) for non-linear change in DNA methylation and inter-individual variation in non-linear change; and Model 3 (M3) for stable sex differences in DNA methylation and sex differences in change of DNA methylation (sex by time interaction). Percentages represent percentage of autosomal CpGs below Bonferroni-corrected threshold (P < 1 × 10−7).CC BY · PubMed Central
Figure 5 Density plots of intercepts for CpGs with (a) directions of change in Model 1 (n = 473 864); (b) non-linear trajectories in Model 2 (n = 52 043); (c) stable sex differences in Model 3 (n = 22 821); (d) sex differences in DNAm change in Model 3 (n = 1768).
Figure 5 Density plots of intercepts for CpGs with (a) directions of change in Model 1 (n = 473 864); (b) non-linear trajectories in Model 2 (n = 52 043); (c) stable sex differences in Model 3 (n = 22 821); (d) sex differences in DNAm change in Model 3 (n = 1768).CC BY · PubMed Central
Figure 6 Enrichment of age-related trajectories in EWASs.
Figure 6 Enrichment of age-related trajectories in EWASs.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. Bates, 2018, Package lme4. Version 1, 17

Cited by

See all 178

Metadata

Authors
Mulder, R. H., Neumann, A., Cecil, C. A. M., Walton, E., Houtepen, L. C., Simpkin, A. J., Rijlaarsdam, J., Heijmans, B. T., Gaunt, T. R., Felix, J. F., Jaddoe, V. W. V., Bakermans-Kranenburg, M. J., Tiemeier, H., Relton, C. L., van IJzendoorn, M. H., & Suderman, M.
Affiliations
  • Leiden University (NL)
  • Jewish General Hospital (CA)
  • King's College London (GB)
  • University of Bristol (GB)
  • Ollscoil na Gaillimhe – University of Galway (IE)
  • Erasmus MC (NL)
  • Leiden University Medical Center (NL)
  • Clinical Child and Family Studies, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
  • Harvard University (US)
  • Department of Psychology, Education and Child Studies, Erasmus University Rotterdam, Rotterdam, The Netherlands
Corresponding author
Suderman, Matthew
Venue
Human Molecular Genetics
Published
2021-01-01
Volume
30
Issue
1
Pages
119-134
ISSN
  • 0964-6906 (ISSN-L)
  • 1460-2083
OpenAlex
W3124817069
Cited by
165
References
116
Citations by year
2026: 27 · 2025: 26 · 2024: 39 · 2023: 33 · 2022: 25 · 2021: 12
FWCI
9.57
Type
journal article
Language
en
Open access
Locations
  • Human Molecular Genetics (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, cc-by)
  • Explore Bristol Research (publishedVersion, cc-by)
  • VU Research Portal (publishedVersion, other-oa)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
  • Leiden Repository (Leiden University) (submittedVersion, cc-by)
  • Pure (University of Bath) (submittedVersion, other-oa)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, cc-by)
  • Data Archiving and Networked Services (DANS) (submittedVersion, cc-by)
  • Lenus, The Irish Health Repository (Dr Steevens Hospital Library) (submittedVersion, cc-by)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Funders
  • Dutch Ministry of Education, Culture, and Science and the Netherlands Organization for Scientific Research (024.001.003)
  • European Research Council (ERC-2014-CoG-648916)
  • Netherlands Organization for Scientific Research (NWO ZonMw VENI (91618147)
  • ESRC/BBSRC (ES/N000382/1)
  • European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie (707404)
  • ESRC and MRC (ES/K000357/1)
  • Netherlands Organization for Scientific Research (016.VICI.170.200)
  • Dutch Ministry of Education, Culture, and Science and the Netherlands Organization for Scientific Research (NWO (024.001.003)
  • MRC Integrative Epidemiology Unit at the University of Bristol (MC_UU_00011/5, MC_UU_00011/4)
  • BBSRC (BB/I025263/1, BBI025751/1)
  • UK Economic and Social Research Council (ES/N000498/1)
  • European Joint Programming Initiative ‘A Healthy Diet for a Healthy Life’
  • European Union’s Horizon 2020 research and innovation programme
  • National Institute of Child and Human Development (R01HD068437)
  • Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) Netherlands Consortium for Healthy Aging (NCHA
  • The UK Medical Research Council and Wellcome (102215/2/13/2)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords
DNA methylation, epigenome-wide association study, child development, developmental trajectories, interindividual variability, sex differences, CpG sites, gene body methylation, enhancer methylation, promoter methylation, immune system development, brain development, blood DNA methylation, late adolescence
MeSH terms
Epigenome, Adolescent, Age Factors, Child, Child, Preschool, Female, Humans, Infant, Infant, Newborn, Male, Sex Characteristics, CpG Islands, DNA Methylation, Epigenesis, Genetic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.